FALCON: A phase III randomised trial of fulvestrant 500 mg vs. anastrozole for hormone receptor-positive advanced breast cancer
Ellis, M.J., Bondarenko, I., Trishkina, E., Dvorkin, M., Panasci, L., Manikhas, A., Shparyk, Y., Cardona-Huerta, S., Cheung, K.-L., Philco-Salas, M.J., Ruiz-Borrego, M., Shao, Z., Noguchi, S., Grinsted, L.M., Fazal, M., Stuart, M., Robertson, J.F.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article